BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Gross profit, 2025
- $34.3B
- YoY, 2025
- −0.2%
- 5-year CAGR
- +2.2%
- 10-year CAGR
- +10.5%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $34.3B | −0.2% |
| 2024 | $34.3B | +0.1% |
| 2023 | $34.3B | −4.7% |
| 2022 | $36.0B | −1.2% |
| 2021 | $36.4B | +18.5% |
| 2020 | $30.7B | +70.2% |
| 2019 | $18.1B | +12.3% |
| 2018 | $16.1B | +9.6% |
| 2017 | $14.7B | +1.4% |
| 2016 | $14.5B | +14.5% |
| 2015 | $12.7B | +5.9% |
| 2014 | $11.9B | +1.5% |
| 2013 | $11.8B | −9.6% |
| 2012 | $13.0B | −16.8% |
| 2011 | $15.6B | +10.1% |
| 2010 | $14.2B | +3.9% |
| 2009 | $13.7B | +10.2% |
| 2008 | $12.4B | +15.9% |
| 2007 | $10.7B | — |